Article Data

  • Views 636
  • Dowloads 117

Original Research

Open Access

EPIDEMIOLOGICAL STUDY OF CUTANEOUS LEISHMANIASIS IN SOME IRAQI PROVINCES

  • Magda A. Ali1,2
  • Ali Khamesipour1
  • Abdulsadah A. Rahi3
  • Mehdi Mohebali4,5
  • Ahmad Akhavan6
  • Alireza Firooz1
  • Hossein Valian Keshavarz4,5

1Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Science (TUMS-IC), Tehran, Iran

2Department of Microbiology, College of Medicine, Wasit University, Kut, Iraq

3Department of Biology, College of Science, Wasit University, Kut, Iraq

4Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

5Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences, Tehran, Iran

6Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

DOI: 10.22374/1875-6859.14.4.4 Vol.14,Issue 4,September 2018 pp.18-24

Published: 24 September 2018

*Corresponding Author(s): Ali Khamesipour E-mail: ali.Khamesipour@gmail.com

PDF (3.1 MB)

Abstract

Background

Cutaneous leishmaniasis (CL) remains a serious public health concern in some parts of Iraq. The aims of this study to report of CL in some parts of Iraq, by different parasitological, cultural, and molecular meth-ods and evaluate sex differences among infected patients. This is the first study conducted to characterize Leishmania species causing CL among Iraqi patients using the sequence analysis of Internal Transcribed Spacer1(ITS1) at Wasit Province.

Methods

A total of 700 cases of suspected CL were referred to the Iraqi clinics and health centres and they checked for Leishmania amastigote using a Giemsa-stain; however, the Novy Macneal Nicolle (NNN) culture led to the growth of promastigotes in all samples, then the samples were examined using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP)-PCR methods.

Results

The present study indicated that the prevalence of CL as follow: AL-Diwaniyah 88(15.1%), Wasit 85 (14.5%), Najaf 79 (13.6%), Thi-Qar76 (13.1%), Basrah 67 (11.5%), Baghdad 65 (11.2%), Diyala 63(10.8%), and Salah-Edin province which recorded lower infection 60 (10.3%), and it appeared in 83.3% by using Giemsa-smeared stain. The highest infection rate (100%) appeared using PCR while the lowest infection (68%) appeared by culture on NNN media. The present study was revealed that the highest infection (60%) was caused by L.major rather than L.tropica (40%). Our results showed that 368 (52.6%) of CL patients were had single lesion and 215 (30.7%) had multiple lesions, and the ulcerative wet type lesions were present in 49.6%, while the nodule dry type lesions were present in 33.7%. The overall prevalence of cutaneous leishmaniasis in the study area was very high (83.3%) having a statistically significant association with sex; males are more prone (56.4%) to CL as compared to females (43.6%).

Conclusions

A clear and reliable bias toward males exists in some tropical diseases, such as leishmaniasis. CL is a major health problem in Iraq and CL caused by many countries including Iraq. Health authorities should be aware of the fact that war and terrorist activities induce expansion of the disease and increase the incidence rate in the situation that access to medical treatment is not easy especially in poor conditions in leishmaniasis endemic areas.

Keywords

Cutaneous leishmaniasis, Gender, Molecular, Human, Iraq

Cite and Share

Magda A. Ali,Ali Khamesipour,Abdulsadah A. Rahi,Mehdi Mohebali,Ahmad Akhavan,Alireza Firooz,Hossein Valian Keshavarz. EPIDEMIOLOGICAL STUDY OF CUTANEOUS LEISHMANIASIS IN SOME IRAQI PROVINCES. Journal of Men's Health. 2018. 14(4);18-24.

References

1. Alvar J, Croft SL, Olliaro P. Chemotherapy in the treatment and control of leishmaniasis. Adv Parasitol 2006;61:227–79.

2. WHO. Communicable Disease Profile Iraq. Working Group on Emergencies, HQ Division of Communicable Disease Control, EMRO, WHO OFFICE, Baghdad. WHO Office, Baghdad. Communicable Disease Toolkit, IRAQ CRISIS. WHO 2003; 39–44.

3. Klein SL. Hormonal and immunological mechanisms mediating sex differences in parasite infection. Parasite Immunol 2004:26:247–64.

4. Marriott I, Huet-Hudson Y. M. Sexual dimorphism in innate immune responses to infectious organisms. Im-munol Res 2006:34:177–92.

5. Travison TG, Araujo AB, O’Donnell AB, Kupelian V, McKinlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 2007:92:196–202.

6. Murback ND, Hans Filho G, Nascimento RA, Nakazato KR, Dorval ME. American cutaneous leishmania-sis: clinical, epidemiological and laboratory studies conducted at a university teaching hospital in Campo Grande, Mato Grosso do Sul, Brazil. An Bras Dermatol 2011:86:55–63.

7. Postigo JA. Leishmaniasis in the World Health Organi-zation Eastern Mediterranean Region. In J Antimicrob Agents 2010;36:62–65.

8. Gillis D, Klaus S, Schnur LF, et al. Diffusely disseminated cutaneous Leishmania major infection in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1995;14:247–9.

9. Alvar J, Vélez ID, Bern C, et al. Leishmaniasis world-wide and global estimates of its incidence. PLoS One. 2012;7:35671.

10. Aronson N. Leishmaniasis in American Soldiers: Parasites from the front. In: Scheld W, Hooper D, (ed), Emerg-ing Infections 7. ASM Press, Washington, DC; 2007.

11. Martina S, Valeriya V, Marie C, et al. Gene-specific sex effects on eosinophil infiltration in leishmaniasis. Biology Sex Diff 2016;7(1):59.

12. Guerra-Silveira F, Abad-Franch F. Sex bias in infectious disease epidemiology: patterns and processes. PLoS One 2013;8:e62390.

13. Alexander J, Bryson K. T helper (h)1/Th2 and Leish-mania: paradox rather than paradigm. Immunol Lett 2005;99:17–23.

14. Snider H, Lezama-Davila C, Alexander J, Satoskar AR. Sex hormones and modulation of immunity against leishmaniasis. Neuroimmunomodulation 2009;16:106–13.

15. Pan AA, Duboise SM, Eperon S, et al. Developmental life cycle of Leishmania– cultivation and charac-terization of cultured extracellular amastigotes. J Eu Microbiol1993;40:213–23.

16. Laskay T, Miko TL, NegesseY, et al. Detection of cuta-neous Leishmania infection in parafin-embedded skin biopsies using the polymerase chain reaction. Trans R Soc Trop Med Hyg1995;89:273–75.

17. Al-Samarai, AM, AlObaidi HS. Cutaneous leishmaniasis in Iraq. J Infect. Developing Countries 2009;3(2):123–29.

18. Talari SA, Shajari G, Talaei R. Clinical finding of cu-taneous leishmaniasis as a new focus of Iran. J Infec Dis 2006;5(2).

19. Ramirez JR, Agudelo S, Muskus C, Alzate JF, Berber-ish C, et al. Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis . J Clin Microbiol 2000;38(10):3768–73.

20. ul Bari A and ber Rahman S. Correlation of clinical, histopathological, and microbiological finding in 60 cases of cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol 2006;72(1):28–32.

21. Faulde M, Schrader J, Heyl G, Amirih M. Differences in transmission seasons as an epidemiological tool for characterization of anthroponotic and zoonotic cutane-ous leishmaniasis in northern Afghanistan. Acta Trop 2008;105(2):131–38.

22. Schönian G, Nasereddin A, Dinse N, et al. PCR diag-nosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 2003:47:349–58.

23. Sharifi I, Poursmaelian S, Aflatoonian MR, et al. Emergence of a new focus of anthroponotic cutaneous leishmaniasis due to L.tropica in rural communities of Bam district after the earthquake, Iran Trop Med Inter Health 2011;4:510–13.

24. Fata A, Khamesipour A, Mohajery M, et al. Whatman paper (FTA cards) for storing and transferring Leish-mania DNA for PCR examination. Iranian J Parasitol 2009;(4):37–42.

25. Rogers MB, Hilley JD, Dickens NJ, et al. Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res 2011;21(12):2129–42.

Abstracted / indexed in

Science Citation Index Expanded Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Social Sciences Citation Index Social Sciences Citation Index contains over 3,400 journals across 58 social sciences disciplines, as well as selected items from 3,500 of the world’s leading scientific and technical journals. More than 9.37 million records and 122 million cited references date back from 1900 to present.

Current Contents - Social & Behavioral Sciences Current Contents - Social & Behavioral Sciences provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in the social and behavioral sciences.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

SCOPUS Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

DOAJ DOAJ is a community-curated online directory that indexes and provides access to high quality, open access, peer-reviewed journals.

CrossRef Crossref makes research outputs easy to find, cite, link, assess, and reuse. Crossref committed to open scholarly infrastructure and collaboration, this is now announcing a very deliberate path.

Portico Portico is a community-supported preservation archive that safeguards access to e-journals, e-books, and digital collections. Our unique, trusted process ensures that the content we preserve will remain accessible and usable for researchers, scholars, and students in the future.

Submission Turnaround Time

Conferences

    Top